Published in Vet Clin North Am Small Anim Pract on May 01, 2003
AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit. Blood (2010) 1.11
Retracted Uterine mast cell tumor: a clinical and cytohistopathological study. J Ovarian Res (2014) 0.85
Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis. BMC Cancer (2014) 0.80
Generation and characterization of novel canine malignant mast cell line CL1. Vet Immunol Immunopathol (2008) 0.78
NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation. Allergy (2012) 0.77
Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours. J Comp Pathol (2012) 0.75
Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012). Vet Comp Oncol (2013) 0.75
Global gene expression analysis of canine cutaneous mast cell tumor: could molecular profiling be useful for subtype classification and prognostication? PLoS One (2014) 0.75
Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor. BMC Vet Res (2014) 0.75
KTN0158, a humanized anti-KIT monoclonal antibody, demonstrates biologic activity against both normal and malignant canine mast cells. Clin Cancer Res (2016) 0.75
Subcutaneous malignant mast cell tumor in a Japanese macaque (Macaca fuscata). Primates (2016) 0.75
Attributing physical and biological impacts to anthropogenic climate change. Nature (2008) 6.91
Historical phenology: grape ripening as a past climate indicator. Nature (2004) 2.76
Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs. J Vet Intern Med (2004) 0.94
Contrast-assisted ultrasound for sentinel lymph node detection in spontaneously arising canine head and neck tumors. Invest Radiol (2006) 0.89
Esophageal dysfunction in four alpaca crias and a llama cria with vascular ring anomalies. J Am Vet Med Assoc (2010) 0.87
Partial resection of the hyoid apparatus during surgical treatment of ectopic thyroid carcinomas in dogs: 5 cases (2011-2013). J Am Vet Med Assoc (2014) 0.84
Hemipelvectomy in dogs and cats: technique overview, variations, and description. Vet Surg (2008) 0.79
Comparison of hematologic and biochemical values for blood samples obtained via jugular venipuncture and via vascular access ports in cats. J Am Vet Med Assoc (2002) 0.79
Biologic behavior and clinical outcome of 25 dogs with canine appendicular chondrosarcoma treated by amputation: a Veterinary Society of Surgical Oncology retrospective study. Vet Surg (2009) 0.78
Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts. BMC Vet Res (2013) 0.77
The expression and role of serotonin receptor 5HTR2A in canine osteoblasts and an osteosarcoma cell line. BMC Vet Res (2013) 0.75
Primary ureteral giant cell sarcoma in a Pomeranian. Vet Clin Pathol (2012) 0.75
Bilateral rostral maxillectomy and nasal planectomy for large rostral maxillofacial neoplasms in six dogs and one cat. J Am Anim Hosp Assoc (2004) 0.75
Pancreatolithiasis and pancreatic pseudobladder associated with pancreatitis in a cat. J Am Anim Hosp Assoc (2004) 0.75
Inhaled flunisolide suppresses the hypothalamic-pituitary-adrenocortical axis, but has minimal systemic immune effects in healthy cats. J Vet Intern Med (2006) 0.75
Clinical outcome of nonnasal chondrosarcoma in dogs: thirty-one cases (1986-2003). Vet Surg (2007) 0.75